
Sign up to save your podcasts
Or
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
5
77 ratings
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
5,020 Listeners
281 Listeners
3,328 Listeners
1,111 Listeners
3,508 Listeners
9,297 Listeners
8,021 Listeners
195 Listeners
510 Listeners
28,587 Listeners
220 Listeners
1,667 Listeners
26 Listeners
389 Listeners
204 Listeners